Despite needing FDA clearance to be on the shelves of your local pharmacy, some popular medicines probably don't work.

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from Fullerton Wellness had an unidentified "black particulate" floating in it.

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Emma Conway says generic and brand-name drugs must have the same milligrams of medicine in them.(Supplied) Typically, after a drug company researches, develops and markets a medication ...

Regardless of where you live in the U.S., chances are you stand in the grocery aisle, price-comparing generic items to name brand ones. You’re not alone, either. Private-label brand sales ...

The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make available to Medicare recipients for $2 in a pilot program. The program ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

which allows drugmakers to get their generic medicines approved for one or several—but not all—approved indications of their brand-name counterparts. Novartis disagrees with the decision and ...